EDBI's Ms Chu said the US-based RMB will enable Singapore's medtech plants to capture substantial, sustainable productivity gains.
Caption: 
EDBI's Ms Chu said the US-based RMB will enable Singapore's medtech plants to capture substantial, sustainable productivity gains.